Full-Service, Fully Committed
CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service Contract Development & Manufacturing Organization (CDMO) for the production of APIs, Drug Products, and associated Packaging Services. Through a growing network of focused investments across Europe and the US organized under Technology Platforms, CordenPharma experts translate complex processes, ideas and projects at any stage of development into high-value products.
CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete cGMP supply chain > from regulated raw materials through intermediates, APIs, commercial-scale Drug Product manufacturing, finished dosage formulation, packaging, clinical trial services, & pharma logistics > resulting in reduced development & manufacturing time and cost.
News & Press
- July 25, 2019
Press Release > ICIG Announces Appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma
- July 24, 2019
Article > Inside the Trenches: End-To-End CDMOs/CMOs
- July 8, 2019
Webinar > Navigating Injectable Combination Device & Drug Product Regulations: How a Full-Service CDMO Supports Pharma
White Paper > Battling Counterfeit Medicine Through Packaging Serialization
6th Int'l Symposium on Phospholipids in Pharma Research
September 9-10, 2019
Phospholipid Research Center
September 10 - 12, 2019
September 16 - 18, 2019
Ocean Place Resort
Long Branch, NJ USA
Browse our library of Brochures, Product Lists, White Papers, Videos & Webinars.
Place an inquiry here > one of our team of experts will get back to you.